Dr Dayan Goodenowe

Dr Goodenowe Research Institute

Dr. Goodenowe’s research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life is as insatiable today as it was 30 years ago. In those 30 years, Dr. Goodenowe invented and developed advanced bioinformatic technologies, designed and manufactured novel supplements, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and numerous cancers.

Quote from linkedin bio
Over the past 30 years, I have invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel and natural biochemical precursors, and identified a treasure trove of biochemical markers that predict numerous diseases including Alzheimer’s and dementia, Parkinson’s, multiple sclerosis, stroke, autism, ALS, multiple system atrophy, various mental illnesses, and cancers.
The study of Plasmalogens is vital in predicting several diseases. Plasmalogens are critical membrane components that help cells communicate with each other and function harmoniously. I have studied Plasmalogens since 2006, and research has expanded to show that Plasmalogens are the root cause of neurodegeneration that leads to Alzheimer’s, Parkinson’s, and MS. My passion is to educate the world about the life-extending benefits possible when Plasmalogen health is harnessed. “

Visit the website